Search results
Results From The WOW.Com Content Network
Hydromorphone, also known as dihydromorphinone, and sold under the brand name Dilaudid among others, is a morphinan opioid used to treat moderate to severe pain. [7] Typically, long-term use is only recommended for pain due to cancer . [ 9 ]
In medicine, specifically in end-of-life care, palliative sedation (also known as terminal sedation, continuous deep sedation, or sedation for intractable distress of a dying patient) is the palliative practice of relieving distress in a terminally ill person in the last hours or days of a dying person's life, usually by means of a continuous intravenous or subcutaneous infusion of a sedative ...
Medical intervention Epidural administration A freshly inserted lumbar epidural catheter. The site has been prepared with tincture of iodine, and the dressing has not yet been applied. Depth markings may be seen along the shaft of the catheter. ICD-9-CM 03.90 MeSH D000767 OPS-301 code 8-910 [edit on Wikidata] Epidural administration (from Ancient Greek ἐπί, "upon" + dura mater) is a method ...
Extended-release (or slow-release) formulations of morphine are those whose effect last substantially longer than bare morphine, availing for, e.g., one administration per day. Conversion between extended-release and immediate-release (or "regular") morphine is easier than conversion to or from an equianalgesic dose of another opioid with ...
mistaken for "QOD" or "qds," AMA style avoids use of this abbreviation (spell out "every day") q.d.a.m. quaque die ante meridiem: once daily in the morning q.d.p.m. quaque die post meridiem: once daily in the evening q.d.s. quater die sumendus: 4 times a day can be mistaken for "qd" (every day) q.p.m. quaque die post meridiem
Morphinone itself is an active opioid, though its potency is closer to codeine than morphine. [citation needed] It is, however, an important precursor and would fall under the purview of the Controlled Substances Act within the United States.
From or to a drug trade name: This is a redirect from (or to) the trade name of a drug to (or from) the international nonproprietary name (INN).
Dihydromorphine acts as an agonist at the μ-opioid with a K i value of 2.5 nM compared to 4.9 nM of morphine, δ-opioid with a K i value of 137 nM compared to 273 nM of morphine and κ-opioid with a K i value of 223 nM compared to 227 nM of morphine. Dihydromorphine is therefore slightly more μ-selective than morphine.